Phase I/II Study of Twenty-Four-Hour Infusion of Irinotecan in Combination with Oral UFT plus Leucovorin for Metastatic Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|76|5|338-341

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.5, 2009-03, pp. : 338-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Study of Irinotecan Alternated with a Weekly Schedule of High-Dose Leucovorin and 48-Hour 5-Fluorouracil Infusion in Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 209-215

Karger

Access to resources Recommend Favorite

5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer

By  

Oncology, Vol. 61, Iss. 1, 2001-07 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

A Phase II Study of Irinotecan Alternated with a Weekly Schedule of Oxaliplatin, High-Dose Leucovorin and 48-Hour Infusion 5-Fluorouracil in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 371-378

Karger

Access to resources Recommend Favorite

A Phase II Trial of Combined Chemotherapy with Oral S-1 and 24-Hour Infusions of Irinotecan plus Bevacizumab in Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 353-359

Karger

Access to resources Recommend Favorite

Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer

By  

Oncology, Vol. 77, Iss. 2, 2009-07 ,pp. : 113-119

Karger

Access to resources Recommend Favorite